Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
RUSH ENTERPRISES, INC. REPORTS SECOND QUARTER 2026 RESULTS, ANNOUNCES THREE-FOR-TWO STOCK SPLIT AND $0.14 PER SHARE DIVIDEND (POST-STOCK SPLIT)
-
IRVINE, Calif. and GREENSBORO, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS) and Qorvo, Inc. (Nasdaq: QRVO) today announced the expected executive leadership team...
-
Hadron partners with Integra and Congregational on a 4-year, £500M UK capacity deal spanning home and church insurance programs.
-
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $980 - $995 million ––...
-
Pemvidutide 2.4 mg delivered a statistically significant and clinically meaningful reduction in heavy drinking days, the primary endpoint of the trial Important secondary endpoints were also met,...
-
LONDON, July 28, 2026 (GLOBE NEWSWIRE) -- Trimontium (the “Firm”), an institutionally backed alternative asset manager specialising in flexible capital solutions with $1.5 billion in assets under...
-
July 27, 2026Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growthIncome from...
-
Raises 2026 Annual Earnings and Revenue Guidance; Conference Call and Webcast scheduled for July 29, 2026 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Ensign...
-
Haffner Energy is opening up its capital structure and acquiring a significant stake in renewable energy production assets to generate recurring revenue.
-
ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...